Debt (Tables)

6 Months Ended

Mar. 31, 2015

Debt [Abstract]

Interest rate swaps

The Company has entered into the following interest rate swaps:

Effective Date	Amount	Fixed Interest Rate	Interest Rate Spread at March 31, 2015	Maturity Date
October 2011	$25,000	1.67%	1.75%	October 2015
June 2012	$40,000	1.88%	1.75%	June 2022
August 2012	$35,000	1.74%	1.75%	June 2022
September 2012	$25,000	3.03%	1.75%	December 2015
September 2012	$25,000	1.24%	1.75%	March 2017
November 2012	$25,000	1.33%	1.75%	November 2015
May 2014	$25,000	1.35%	1.75%	May 2018
November 2014	$25,000	1.26%	1.75%	June 2018
March 2015	$25,000	1.49%	1.75%	March 2019

Derivatives designated as hedging instruments

At March 31, 2015 and September 30, 2014, the interest rate swap contracts were reflected in the consolidated balance sheets as follows:

Derivatives	March 31, 2015			September 30, 2014
Current assets:
Other current assets	$	-		$	324
Long-term assets:
Other assets		-			2,133
Current liabilities:
Other current liabilities		(1,360	)		(1,808	)
Long-term liabilities:
Other liabilities		(1,502	)		(319	)
Total derivatives	$	(2,862	)	$	330

Loss recognized on derivatives

The loss recognized on derivatives was as follows:

	Location of
Derivatives in	Loss	Amount of				Amount of
Cash Flow	Recognized in	Loss Recognized				Loss Recognized
Hedging	Income on	in Income				in Income
Relationships	Derivative	on Derivatives				on Derivatives
		Three Months ended March 31,				Six Months ended March 31,
		2015		2014		2015		2014
Interest rate swaps	Interest expense		$(996)		$(1,054)		$(2,073)		$(2,130)

The Company recognized the following gains or losses in AOCI:

					Location of
					Gain or
					(Loss)	Amount of Loss
					Reclassified	Reclassified from
	Amount of				From	AOCI into
Derivatives in	(Loss) Recognized in				AOCI into	Income
Cash Flow	AOCI on Derivatives				Income	(Effective Portion*)
Hedging Relationships	March 31,2015		March 31,2014		(EffectivePortion*)	March 31, 2015		March 31, 2014
Interest rate swaps		$(3,212)		$(472)	Interest expense		$(1,265)		$(1,299)
*There is no ineffective portion or amount excluded from effectiveness testing.